156 related articles for article (PubMed ID: 35315178)
1. Novel classification and risk model based on ferroptosis-related lncRNAs to predict oncologic outcomes for gastric cancer patients.
Yue Q; Bai J; Wang F; Xue F; Li L; Duan X
J Biochem Mol Toxicol; 2022 Jul; 36(7):e23052. PubMed ID: 35315178
[TBL] [Abstract][Full Text] [Related]
2. A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer.
Wei J; Zeng Y; Gao X; Liu T
BMC Cancer; 2021 Nov; 21(1):1221. PubMed ID: 34774009
[TBL] [Abstract][Full Text] [Related]
3. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
4. Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment.
Wang Y; Lu G; Xue X; Xie M; Wang Z; Ma Z; Feng Y; Shao C; Duan H; Pan M; Ding P; Li X; Han J; Yan X
Front Immunol; 2022; 13():903758. PubMed ID: 36016939
[TBL] [Abstract][Full Text] [Related]
5. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes and potential therapies prediction of subgroups based on a ferroptosis-related long non-coding RNA signature for gastric cancer.
Geng H; Qian R; Zhang L; Yang C; Xia X; Wang C; Zhao G; Zhang Z; Zhu C
Aging (Albany NY); 2022 Aug; 14(15):6358-6376. PubMed ID: 35969182
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients.
Liu G; Ma JY; Hu G; Jin H
PLoS One; 2021; 16(7):e0254368. PubMed ID: 34252149
[TBL] [Abstract][Full Text] [Related]
8. Identification of Ferroptosis-Associated Long Noncoding RNA Prognostic Model and Tumor Immune Microenvironment in Thyroid Cancer.
Lin Y; Gan F; He X; Deng H; Li Y
J Immunol Res; 2022; 2022():5893998. PubMed ID: 35915656
[TBL] [Abstract][Full Text] [Related]
9. Potential Key Markers for Predicting the Prognosis of Gastric Adenocarcinoma Based on the Expression of Ferroptosis-Related lncRNA.
Cai Y; Wu S; Jia Y; Pan X; Li C
J Immunol Res; 2022; 2022():1249290. PubMed ID: 35528617
[TBL] [Abstract][Full Text] [Related]
10. A ferroptosis-associated lncRNAs signature predicts the prognosis of hepatocellular carcinoma.
Wang D; Zhang L; Zhang Y; Zhang Y; Xu S
Medicine (Baltimore); 2022 Jul; 101(28):e29546. PubMed ID: 35839000
[TBL] [Abstract][Full Text] [Related]
11. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Therapeutic Response of Gastric Cancer.
Xiao S; Liu X; Yuan L; Wang F
Front Cell Dev Biol; 2021; 9():736682. PubMed ID: 34926441
[No Abstract] [Full Text] [Related]
12. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.
Zhang X; Jiang Y; Xie Y; Leng X; Song F
DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of Immune Infiltrates of Ferroptosis-Related Long Noncoding RNA and Prediction of Colon Cancer Patient Prognoses.
Chen W; Chen Y; Liu L; Wu Y; Fu P; Cao Y; Xiong J; Tu Y; Li Z; Liu Y; Jie Z
J Immunol Res; 2022; 2022():9480628. PubMed ID: 35265722
[TBL] [Abstract][Full Text] [Related]
14. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
Wang JM; Li X; Yang P; Geng WB; Wang XY
BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of Ferroptosis-Related Markers for the Clinical and Biological Value in Gastric Cancer.
Shao Y; Jia H; Li S; Huang L; Aikemu B; Yang G; Zhang S; Sun J; Zheng M
Oxid Med Cell Longev; 2021; 2021():7007933. PubMed ID: 34745421
[TBL] [Abstract][Full Text] [Related]
17. Identification of the ferroptosis-related ceRNA network related to prognosis and tumor immunity for gastric cancer.
Xiang Z; Zhou X; Mranda GM; Xue Y; Wang Y; Wei T; Liu J; Ding Y
Aging (Albany NY); 2022 Jul; 14(14):5768-5782. PubMed ID: 35835721
[TBL] [Abstract][Full Text] [Related]
18. Identification of Ferroptosis-Related Long Noncoding RNA and Construction of a Novel Prognostic Signature for Gastric Cancer.
Chen W; Feng Z; Huang J; Fu P; Xiong J; Cao Y; Liu Y; Tu Y; Li Z; Jie Z; Xiao T
Dis Markers; 2021; 2021():7724997. PubMed ID: 34394774
[TBL] [Abstract][Full Text] [Related]
19. Ferroptosis‑related long non‑coding RNAs and the roles of LASTR in stomach adenocarcinoma.
Wang G; Sun L; Wang S; Guo J; Xiao R; Li W; Qi W; Qiu W
Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35137922
[TBL] [Abstract][Full Text] [Related]
20. A prognostic risk prediction model based on ferroptosis-related long non-coding RNAs in bladder cancer: A bulk RNA-seq research and scRNA-seq validation.
Xiang X; Guo Y; Chen Z; Zhang F; Huang J; Qin Y
Medicine (Baltimore); 2022 Dec; 101(51):e32558. PubMed ID: 36595859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
